What is Prism Medico and Pharmacy Ltd (512217) share price return in the past 10 years?

Prism Medico and Pharmacy Ltd share price has appreciated 3.3% annually (CAGR) over the past ten years.

What is the share price of Prism Medico and Pharmacy Ltd (512217)?

Company share prices are keep on changing according to the market conditions. The current trading price of Prism Medico and Pharmacy Ltd (512217) on 16-Jun-2026 16:59:59 at 16:59 is 27.95.

What is the P/E ratio of Prism Medico and Pharmacy?

The latest standalone P/E ratio of Prism Medico and Pharmacy as of 16-Jun-2026 is 114.78.

What is the P/B ratio of Prism Medico and Pharmacy Ltd (512217)?

The latest standalone P/B ratio of Prism Medico and Pharmacy Ltd (512217) as of 16-Jun-2026 is 1.60.

What is the 52-week high and low of Prism Medico and Pharmacy Ltd (512217)?

The 52-week high of Prism Medico and Pharmacy Ltd (512217) is Rs. 34.49 and the 52-week low is Rs. 12.49.

Prism Medico and Pharmacy Ltd (512217) Share Analysis – Quality, Valuation Zone & Price Trend & DeciZen Rating

Name: Prism Medico and Pharmacy Ltd (512217)
Brand: Prism Medico and Pharmacy

Prism Medico and Pharmacy Ltd (512217)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 512217 NSE: Trading | Small Cap | Prism Medico Share Price

Prism Medico and Pharmacy Ltd (512217)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 512217 NSE: Trading | Small Cap | Prism Medico Share Price

Key Metrics

Valuation Multiples

Market Cap

₹37 Cr.

Current Price

₹28

52-Week Low / High

₹12 / 34

TTM EPS

₹0.2

TTM Sales

₹2.4 Cr.

Book Value per Share

₹16.9

P/E Ratio

114.78

Industry PE

Price to Book (P/B)

1.60

Higher than its 5-year historical median

Price to Sales (P/S)

15.03

Higher than its 5-year historical median

EV/EBITDA

83.90

Higher than its 5-year historical median

Dividend Yield

Profitability Efficiency

Return on Equity (ROE)

-0.32%

Underperforms industry median

Return on Capital Employed (ROCE)

-0.42%

Underperforms industry median

Return on Assets (ROA)

-0.32%

Operating Profit Margin

-12.1%

Net Profit Margin

-7.71%

Gross Profit Margin

-9.8%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-78.5%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

25.49%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹9 Cr.

Equity

₹13.6 Cr.

Face Value

₹10

All Time Low / High

₹3.00 / 85.15

Prism Medico and Pharmacy stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Prism Medico and Pharmacy Ltd a good quality company?

Prism Medico and Pharmacy Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Prism Medico and Pharmacy Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Prism Medico and Pharmacy Ltd vs industry peers?

Prism Medico and Pharmacy Ltd revenue CAGR is -52.80%, compared to the industry median CAGR of 0%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Prism Medico and Pharmacy Ltd?

Promoters hold 25.49% of the Prism Medico and Pharmacy Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Prism Medico and Pharmacy Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 4.4% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	-0.5%	-3.1%	0.4%	2.3%	-0.5%	-1.4%	-3.9%	-0.7%	-0.1%	-0.4%	-
Value Creation Index ⓘ	-1.0	-1.2	-1.0	-0.8	-1.0	-1.1	-1.3	-1.1	-1.0	-1.0	-
Growth Parameters ⓘ
Sales ⓘ	0.1	0.1	21	36.3	26.9	16.8	8.4	1.3	2.9	0.6	2
Sales YoY Gr.	-	0%	23,188.9%	73.2%	-25.9%	-37.7%	-49.6%	-85%	130.7%	-78.5%	-
Adj EPS ⓘ	-0	-0.4	-0	0.6	-0.1	-0.2	-0.6	-0.1	-0.1	-0.1	0.2
YoY Gr.	-	NA	NA	NA	-113.1%	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	8.2	21.1	21.1	21.7	21.5	21.3	20.7	25	25	24.9	16.9
Adj Net Profit ⓘ	-0	-0.2	-0	0.4	-0.1	-0.1	-0.4	-0.1	-0.1	-0.1	0
Cash Flow from Ops. ⓘ	0.1	-0.8	0	-1.2	-4.4	-0.1	-2.4	3	-0	-0	-
Debt/CF from Ops. ⓘ	1.5	0	0	0	0	0	0	0	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	24.1%	-52.8%	-57.9%	-78.5%
Adj EPS ⓘ	NA	NA	NA	NA
BVPSⓘ	13.2%	2.9%	6.3%	-0.3%
Share Price	3.3%	25.8%	4.2%	87.1%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	-0.5	-3.2	-0.1	2.9	-0.4	-1	-2.9	-0.6	-0.4	-0.4	1.2
Op. Profit Mgn % ⓘ	-74.2	-318	0.5	0.3	-0.2	-1	-5.8	-7.6	-4.7	-12.1	16.8
Net Profit Mgn % ⓘ	-9.8	-261.3	-0.1	1	-0.2	-0.8	-4.4	-6	-2.2	-8.7	13.3
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0	0	0
Working Cap Days ⓘ	6,214	5,777	26	42	178	423	685	3,925	1,869	8,704	1,238
Cash Conv. Cycle ⓘ	24	1,817	15	10	72	258	506	3,330	1,370	6,002	1,222

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	0.09	0.09	20.96	36.31	26.89	16.76	8.44	1.27	2.93	0.63
Operating Expenses ⓘ +	0.15	0.36	20.87	36.20	26.94	16.93	8.93	1.37	3.06	0.71
Manufacturing Costs	0	0	0	0	0	0	0	0	0	0
Material Costs	0.08	0	20.63	35.21	26.61	16.67	8.63	1.14	2.56	0.45
Employee Cost	0	0.01	0.10	0.25	0.22	0.17	0.19	0.05	0.03	0.04
Other Costs ⓘ	0.06	0.36	0.14	0.75	0.11	0.09	0.12	0.18	0.47	0.22
Operating Profit ⓘ	-0.06	-0.28	0.09	0.10	-0.05	-0.16	-0.49	-0.10	-0.14	-0.08
Operating Profit Margin (%)	-74.2%	-318.0%	0.4%	0.3%	-0.2%	-1.0%	-5.8%	-7.6%	-4.7%	-12.1%
Other Income ⓘ +	0.06	0.07	0	0.22	0	0	0	0	0.12	0.02
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	0	0	0	0	0	0.01	0
Depreciation ⓘ	0.01	0.02	0.04	0.03	0.02	0.01	0.01	0.01	0.01	0
Profit Before Tax ⓘ	-0.01	-0.23	0.05	0.29	-0.07	-0.18	-0.50	-0.10	-0.03	-0.07
Tax ⓘ	0	0	0.07	-0.08	-0.02	-0.05	-0.13	-0.03	-0.01	-0.02
Profit After Tax	-0.01	-0.23	-0.02	0.37	-0.05	-0.13	-0.37	-0.08	-0.02	-0.05
PAT Margin (%)	-9.8%	-261.0%	-0.1%	1.0%	-0.2%	-0.8%	-4.4%	-6.0%	-0.7%	-7.7%
Adjusted EPS (₹)	-0.0	-0.4	-0.0	0.6	-0.1	-0.2	-0.6	-0.1	-0.0	-0.1
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Prism Medico - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	1.63	12.80	12.78	13.15	13.06	12.93	12.55	15.16	15.14	15.09
Share Capital ⓘ	1.99	6.06	6.06	6.06	6.06	6.06	6.06	6.06	6.06	6.06
Reserves ⓘ	-0.36	6.74	6.72	7.09	6.99	6.86	6.49	9.10	9.08	9.03
Debt +	0.07	0	0	0	0	0	0	0	0	0
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	0.07	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.08	0	0	3.57	8.45	8.44	0	0	0.03	0
Others Liabilities ⓘ	0.07	0.25	0.16	0.25	0.07	0.11	-0.17	0.02	-0.15	0.23
Total Liabilities ⓘ	1.85	13.05	12.94	16.97	21.57	21.48	12.38	15.18	15.02	15.33
Fixed Assets
Net Fixed Assets ⓘ +	0	0.16	0.11	0.09	0.07	0.06	0.05	0.04	0.03	0.03
Gross Block	0.05	0.22	0.22	0.22	0.22	0.22	0.05	0.04	0.03	0.03
Accumulated Depreciation	0.05	0.06	0.11	0.13	0.15	0.16	0	0	0	0
CWIP ⓘ	0	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	10	11.25	10	1.94	1.94	0	0	0	0
Inventories	0	0.79	0.89	0.96	0.05	4.85	6.77	6.77	6.77	6.77
Trade Receivables	0.09	0	0	3.76	18.34	13.51	4.88	4.76	3.69	3.58
Cash Equivalents	0.59	1.40	0.04	0.12	0.11	0.08	0.06	0.10	0.08	0.07
Others Assets ⓘ	1.18	0.70	0.65	2.05	1.07	1.05	0.63	3.51	4.45	4.88
Total Assets ⓘ	1.85	13.05	12.94	16.97	21.57	21.48	12.38	15.18	15.02	15.33

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0.05	-0.82	-1.23	-4.36	-0.05	-2.38	2.95	-0.01	-0.02
PBT ⓘ	-0.01	-0.23	0.29	-0.07	-0.18	-0.50	-0.10	-0.03	-0.07
Adjustment ⓘ	0.01	0.02	0.03	0.02	0.01	0.01	2.96	0.01	0.01
Changes in Working Capital ⓘ	0.04	-0.61	-1.5	-4.28	0.11	-1.89	0.37	0.01	0.04
Tax Paid ⓘ	0	0	-0.06	-0.03	0	0	-0.27	0	0
Cash Flow From Investing Activity ⓘ +	0.46	0.30	1.25	4.36	0.02	2.35	-2.91	0	0
Capex	0	-0.17	0	0	0	0	0	0	0
Net Investments	0	0	1.25	8.06	0	1.94	0	0	0
Others ⓘ	0.46	0.47	0	-3.70	0.02	0.41	-2.91	0	0
Cash Flow From Financing Activity ⓘ +	0.05	1.33	0.06	-0	-0	-0	-0	-0.01	-0
Net Proceeds from Shares ⓘ	0	1.40	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0.06	0	0	0	0	0	0
Interest Paid ⓘ	0	0	-0	-0	-0	-0	-0	-0.01	-0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0
Others ⓘ	0.05	-0.07	0	0	0	0	0	0	0
Net Cash Flow ⓘ	0.56	0.81	0.08	-0.01	-0.03	-0.03	0.04	-0.01	-0.02

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	-0.51	-3.15	-0.15	2.85	-0.38	-1	-2.9	-0.55	-0.14	-0.32
ROCE (%)	-0.49	-3.11	0.37	2.26	-0.52	-1.35	-3.91	-0.74	-0.14	-0.42
Asset Turnover Ratio	0.05	0.01	1.61	2.43	1.4	0.78	0.5	0.09	0.19	0.04
PAT to CFO Conversion(x)	N/A	N/A	N/A	-3.32	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	365	0	0	37.80	150	346.70	397.60	1,384.70	527.20	2,100.80
Inventory Days	0	3,314.30	14.60	9.30	6.90	53.30	251.10	1,944.80	844.80	3,910.90
Payable Days	365	0	0	37	82.40	185	0	0	4.40	0

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Prism Medico and Pharmacy Ltd FAQs

The current trading price of Prism Medico on 16-Jun-2026 16:59 is ₹27.95.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 15-Jun-2026 the market cap of Prism Medico stood at ₹36.73 Cr

The latest P/E ratio of Prism Medico as of 15-Jun-2026 is 114.8.

The latest P/B ratio of Prism Medico as of 15-Jun-2026 is 1.60.

The 52-week high of Prism Medico is ₹34.49 and the 52-week low is ₹12.49.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Prism Medico is ₹2.44 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Prism Medico and Pharmacy Ltd is a below average quality company.

The key valuation ratios of Prism Medico and Pharmacy Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Prism Medico and Pharmacy Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Prism Medico and Pharmacy Ltd

Woolite Mercantile Company Ltd.(WMCL) was incorporated on February 21, 1985 with the Registrar of Companies, Maharashtra, Mumbai, as a public limited xompany and obtained the certificate of commencement of business on March 8,1985.

Business area of the company:

The main object of the company was to carry on the trading in goods and commodities.. During the year ended March 31, 2008 the company earned Interest Income from loans and advances given and is presently engaged in the investing in shares and other securities and other financing activities.

2005-2006 During the financial year 2005-06, the income from share trading, mutual fund trading, mutual fund brokerage, etc increased due to better market conditions. So total income from operations during the financial year increased from Rs.0.94 lakh during the previous year to Rs.4.52 lakh. However, as the company sold its major investment in the financial year 2004-05 itself, its other income reduced from Rs.24.47 lakh to Rs.4.88 lakh. As a result the total income during the year reduced from Rs.27.42 lakh to Rs.9.40 lakh. Due to reduction in the expenses the net profit increased from Rs.1.07 lakh to Rs.4.09 lakh during the year.

2006-2007 During the financial year 2006-07, the company restricted its activities and did not carry any share trading activities. It carried on only mutual fund trading. So the total income & net profit during the year reduced to Rs.2.92 lakh & Rs.0.62 lakh respectively in comparison to previous year figures of Rs.9.40 lakh & Rs.4.09 lakh respectively.

2007-2008 In the financial year 2007-2008 the only income was interest from advances given, since the advances given was higher during the current year in comparison to previous year, hence the total income during the year increased to Rs.3.09 lakh in comparison to Rs.2.92 lakh during the previous year. However, as the expenses in the current year was also lower as compared to previous year as there were no business activities in the company, net profit during the year increased slightly to Rs.0.89 lakh from Rs.0.62 lakh during the previous year.

Prism Medico and Pharmacy Ltd (512217)

Prism Medico and Pharmacy Ltd (512217)

Prism Medico and Pharmacy stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Prism Medico - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Prism Medico and Pharmacy Ltd FAQs

About Prism Medico and Pharmacy Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Prism Medico and Pharmacy Ltd (512217)

Prism Medico and Pharmacy Ltd (512217)

Prism Medico and Pharmacy stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Prism Medico - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Prism Medico and Pharmacy Ltd FAQs

What is the share price of Prism Medico?

What is the market cap of Prism Medico?

What is the P/E ratio of Prism Medico?

What is the P/B ratio of Prism Medico?

What is the 52-week high and low of Prism Medico?

What is the TTM revenue of Prism Medico?

Is Prism Medico and Pharmacy Ltd a good quality company?

Is Prism Medico and Pharmacy Ltd undervalued or overvalued?

Is Prism Medico and Pharmacy Ltd a good buy now?

About Prism Medico and Pharmacy Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.